{"0":{"dur":4,"text":"CHANG: Hello. I want to welcome you to this\npanel today on the emerging global health"},"5":{"dur":6,"text":"crisis of noncommunicable diseases. And we\nhave a very distinguished panel as always"},"11":{"dur":3,"text":"here at the council to discuss the matter,\nand they're going to talk about a task force,"},"15":{"dur":3,"text":"which -- I didn't know this.\nThe Council does a bunch of reports all the"},"18":{"dur":6,"text":"time issuing all sorts of relevant and important\ninformation, but this is -- of the seventy-two"},"25":{"dur":5,"text":"task force reports that the Council has published,\nthis is the first one on global health. So"},"31":{"dur":4,"text":"it gives you an indication of just how important\nthe issue that we're discussing today is."},"36":{"dur":5,"text":"To my immediate left is Tom Donilon. He is\nvice chair at O'Melveny in Washington. He's"},"41":{"dur":5,"text":"returned to the firm for the fourth time after\nserving in the Obama administration most notably"},"46":{"dur":4,"text":"as national security advisor responsible,\nas you can imagine, for steering the administration's"},"51":{"dur":3,"text":"foreign policy, intelligence and military\nefforts."},"54":{"dur":4,"text":"President Obama was quoted as saying that\nhe was the most effective national security"},"59":{"dur":6,"text":"advisor our country has ever had. Not a bad\nendorsement from your boss, the commander"},"65":{"dur":3,"text":"in chief.\n(APPLAUSE)"},"68":{"dur":6,"text":"A leading national security expert with deep\nexperience of course in global strategy, cybersecurity,"},"75":{"dur":6,"text":"financial services, Mr. Donilon has a golden\nRolodex, perhaps even a platinum one in fact,"},"81":{"dur":5,"text":"he's -- because he has served as the president's\npersonal emissary on a number of missions"},"87":{"dur":4,"text":"to different world leaders from China, to\nRussia, Saudi Arabia and Israel."},"92":{"dur":4,"text":"Tom has advised three presidents, beginning\nwith President Carter. He was assistant secretary"},"96":{"dur":6,"text":"of state as well in the Clinton administration,\nand he is also back at O'Melveny working on"},"102":{"dur":7,"text":"the firm's public interest and pro bono initiatives\nSo he's here obviously doing the work of the"},"109":{"dur":3,"text":"angels.\nBarbara Byrne is to his left. She is vice"},"112":{"dur":4,"text":"chair in investment banking at Barclays, responsible\nfor leading the firm's relationships with"},"117":{"dur":8,"text":"a diverse group of blue chip Fortune 100 corporate\nclients including GE, IBM, U.S. Steel, Microsoft"},"125":{"dur":3,"text":"and others of course.\nByrne joined Barclays from Lehman Brothers,"},"129":{"dur":5,"text":"where during her very distinguished twenty-eight-year\ncareer she became the first and only woman"},"134":{"dur":5,"text":"to achieve a vice chair position in Lehman's\n158-year history."},"140":{"dur":5,"text":"She -- just a couple of career highlights\nrelevant to today's discussion. In 2007, she"},"145":{"dur":6,"text":"led teams advising the $62 billion spin-off\nof Kraft and later Philip Morris International,"},"152":{"dur":8,"text":"as well as GE on her -- on their $11 billion\nsale of its plastics division."},"160":{"dur":5,"text":"To her left is Tom Bollyky. Tom is the senior\nfellow for global health, economics and eevelopment"},"165":{"dur":4,"text":"here at the council. He's also an adjunct\nprofessor of law at Georgetown, as well as"},"169":{"dur":3,"text":"a consultant to the Bill and Melinda Gates\nFoundation."},"173":{"dur":4,"text":"Prior to coming to the council, he was at\nthe Office of the U.S. Trade Representative"},"177":{"dur":4,"text":"where he held negotiations for pharmaceuticals,\nbiotechnology and medical technologies to"},"182":{"dur":4,"text":"the U.S. Republic of Korea free trade agreement.\nWe were talking about Seoul a lot earlier"},"187":{"dur":4,"text":"(inaudible) in the back. And he represented\nUSTR in the negotiations with China on the"},"192":{"dur":4,"text":"safety of food and drug imports.\nHe was also, again relevant to today's discussion,"},"196":{"dur":4,"text":"a Fulbright Scholar to South Africa where\nhe worked as the staff attorney to the AIDS"},"201":{"dur":6,"text":"Law Project on treatment access issues related\nto HIV and AIDS. Obviously health policy is"},"207":{"dur":3,"text":"an important part of his portfolio and why\nhe's here today."},"211":{"dur":4,"text":"Because we're going to talk, despite the fact\nthat my business gives so much breathless"},"216":{"dur":7,"text":"attention to tropical diseases like Ebola\nand super viruses and et cetera, it is not"},"223":{"dur":5,"text":"the exotic parasites or the tropical viruses\nthat are of pressing concern in today's global"},"229":{"dur":4,"text":"health perspective.\nReally we're talking about the threat and"},"234":{"dur":6,"text":"the crisis of noncommunicable diseases, from\nthe increase in the risk of premature death,"},"240":{"dur":5,"text":"premature death being death before the age\nof sixty. We're talking about problems that"},"245":{"dur":5,"text":"have been intransigent in our culture: obesity,\ncardiovascular disease, preventable cancers,"},"250":{"dur":4,"text":"adult-onset diabetes.\nWhat we have found in this task force is that"},"255":{"dur":3,"text":"there are cheap, affordable, and very effective\npreventions. And that's part of why we're"},"258":{"dur":4,"text":"here to talk today, but I want to start off\nwith Tom. You know, we discussed how this"},"263":{"dur":4,"text":"is the first task force report on health.\nWhy is the Council, when it should be counting"},"268":{"dur":5,"text":"missiles and dealing with terrorist threats,\ntalking about obesity and cardiovascular disease?"},"273":{"dur":5,"text":"DONILON: Thanks Juju, and nice to be here\nwith everybody. And as you said, it was an"},"278":{"dur":3,"text":"unusual task force for the Council in that\nit was -- I think there's been seventy-two"},"282":{"dur":4,"text":"reports since 1995 and this was the first\none on global health. It was an extraordinary"},"287":{"dur":5,"text":"group of people as well from a multidisciplinary\ngroup of -- group of fields."},"292":{"dur":3,"text":"That was the question we asked ourselves at\nthe beginning. Mitch Daniels and I co-chaired"},"295":{"dur":7,"text":"this task force, and the first meetings were\non the topic that you asked about, which is"},"302":{"dur":5,"text":"why is the Council on Foreign Relations doing\nthis? What are the U.S. interests involved?"},"307":{"dur":4,"text":"If we identify U.S. interests, what can the\nUnited States do about this? What can the"},"312":{"dur":4,"text":"United States do about this in terms of its\nresources available? How effective can be"},"316":{"dur":4,"text":"it be and in what sort of timeframe? Those\nare the very questions, and we didn't presuppose"},"320":{"dur":2,"text":"any answers.\nCHANG: And Mitch Daniels, you were saying,"},"322":{"dur":1,"text":"was quite skeptical.\nDONILON: Yeah. I think there were a number"},"324":{"dur":6,"text":"of people who were skeptical. And so we decided\nas a group that this would be a data-driven"},"330":{"dur":3,"text":"exercise, that we would go where the evidence\nled us and come to the conclusions that the"},"334":{"dur":3,"text":"evidence -- the evidence took us to.\nYou know, a lot of -- I've been on a number"},"338":{"dur":6,"text":"of task forces. In many cases, they don't\nabide by the old Daniel Patrick Moynihan maxim"},"344":{"dur":3,"text":"that you're entitled to your opinions but\nnot your own facts. There's a lot of opinion"},"348":{"dur":5,"text":"in foreign policy and national security. Here\nit really was quite unusual that we really"},"353":{"dur":3,"text":"did really go with the data -- where the data\ntook us."},"357":{"dur":4,"text":"And indeed, if you look at the report, it\nis really full of data. And -- and -- and"},"362":{"dur":9,"text":"in addition to the printed report, there's\nan online annex with analysis, methodological"},"371":{"dur":5,"text":"explanations and country-by-country reviews\nof what the data told us about various threats"},"376":{"dur":3,"text":"in those countries.\nNow on the U.S. -- on the U.S. interests,"},"379":{"dur":9,"text":"one is that, as you said correctly, noncommunicable\ndiseases are the biggest threat to the health"},"389":{"dur":3,"text":"of populations in low and moderate-income\ncountries by far."},"393":{"dur":7,"text":"Indeed, the World Economic Forum and, as indicated,\nit concluded in a report that it did that"},"400":{"dur":7,"text":"this was the biggest threat to global development\nof any threat other than climate change. So"},"407":{"dur":5,"text":"it's a major threat to global -- to global\npopulations and global development and global"},"413":{"dur":3,"text":"economics going forward.\nThe World Economic Forum had published a figure"},"417":{"dur":5,"text":"on this indicating that they -- they concluded\nthat the cost in low and moderate-income or"},"422":{"dur":6,"text":"developing countries, was their -- was their\ngrouping, the cost would be $23.1 trillion"},"428":{"dur":5,"text":"between now and 2030 of noncommunicable diseases,\nan extraordinary amount of money equal to"},"433":{"dur":2,"text":"the entire GDP of these countries last -- last\nyear."},"436":{"dur":5,"text":"So an enormously important issues with respect\nto these countries' economic futures. And"},"442":{"dur":3,"text":"from the U.S. interests of course, that -- that\n-- that is a U.S. interest. It's a U.S. interest"},"446":{"dur":5,"text":"in terms of economic growth and stability\naround the world, stability of countries that"},"451":{"dur":6,"text":"we care deeply about, and the problem is only\ngoing to increase because, as you indicated,"},"458":{"dur":4,"text":"this is a problem really of younger populations\nin the low and moderate-income countries."},"462":{"dur":7,"text":"Additionally, we determined that this undermines\nexisting U.S. programs. We have had tremendous"},"470":{"dur":4,"text":"global health successes in the AIDS area,\nfor example, but the very same populations"},"475":{"dur":6,"text":"that we've had tremendous success in saving\nare populations who are subject to these noncommunicable"},"481":{"dur":4,"text":"diseases.\nSo we have one platform of successful operations"},"485":{"dur":6,"text":"on programs that are underway being directly\nundercut by -- by the NCD -- by the NCD problem."},"492":{"dur":4,"text":"Additionally, more broadly, this really is\nabout U.S. leadership in health. U.S. -- U.S."},"496":{"dur":5,"text":"leadership in health is essential. It has\nbeen and is an area in the world that we're"},"502":{"dur":5,"text":"looked to. It's -- U.S. leadership is essential,\nand it's very important reputationally for"},"508":{"dur":4,"text":"the United States.\nAnd last I would say that we also saw that"},"512":{"dur":3,"text":"there were real opportunities here for us\nto work bilaterally with important countries"},"516":{"dur":3,"text":"around the world on this, including countries\nlike China and India."},"519":{"dur":5,"text":"So we determined, again, across a whole range\nof interests that the U.S. had -- had significant"},"524":{"dur":3,"text":"interest here. And most importantly, and we'll\ntalk about this as we go through this, that"},"528":{"dur":5,"text":"there were things that we could do at -- in\nan affordable way that could show really pretty"},"534":{"dur":4,"text":"extraordinary results.\nCHANG: So Tom, let me skip over Barbara for"},"538":{"dur":6,"text":"a second and get you to come in on this discussion\nabout sort of how we got to this place. Why"},"544":{"dur":5,"text":"is it that it's trending in this direction\nand -- and what did the task force recommend"},"549":{"dur":4,"text":"in terms of what the U.S. could do to act\nin a leadership role, much like it did in"},"554":{"dur":4,"text":"the AIDS crisis?\nBOLLYKY: Great. Well let me start by thanking"},"559":{"dur":4,"text":"Tom and Mitch, who unfortunately couldn't\nbe here today, for great leadership of this"},"564":{"dur":7,"text":"task force. And we have a number of task force\nmembers here, Barbara being one of them, Nancy"},"571":{"dur":3,"text":"Brinker being another. And I want to thank\nthem all for this -- for their great service"},"575":{"dur":5,"text":"on this task force.\nSo --what's new about heart disease, cancer,"},"581":{"dur":5,"text":"diabetes being a problem? They've existed\nin high-income countries for decades now."},"587":{"dur":3,"text":"Why are we concerned about what's happening\nin low and middle-income countries?"},"591":{"dur":5,"text":"And we're concerned because these diseases\nare increasing in prevalence much faster in"},"597":{"dur":7,"text":"much younger populations and having much worse\noutcomes than ever happened in developed countries."},"604":{"dur":6,"text":"What are some of the stats behind that?\nWell, deaths from noncommunicable disease,"},"610":{"dur":6,"text":"again, cancer, cardiovascular disease, diabetes,\nchronic respiratory illnesses, increased 53"},"616":{"dur":6,"text":"percent since 1990 in low and middle-income\ncountries. There are more than 8 million deaths"},"622":{"dur":6,"text":"that occur in populations fifty-nine and younger\nfrom these -- these diseases in low and middle-income"},"628":{"dur":2,"text":"countries.\nAnd the rates are growing worse in the very"},"631":{"dur":6,"text":"same countries that we've invested in to address\nother global health issues. Why is this happening?"},"638":{"dur":6,"text":"Well, it starts actually with a bit of good\nnews, which is life expectancies are increasing"},"644":{"dur":4,"text":"in low and middle-income countries, but most\nof that increase is driven by improvements"},"648":{"dur":4,"text":"in child mortality.\nSo populations are living longer, but you've"},"653":{"dur":6,"text":"not seen the same increases in wealth or improvements\nin health systems that you saw in higher-income"},"660":{"dur":7,"text":"settings. For instance, when OECD countries\nhit a median age -- life expectancy age of"},"667":{"dur":5,"text":"fifty-nine, the GDP per capita in those countries\nwas $4,400."},"673":{"dur":6,"text":"Low-income countries just hit that threshold,\nand the GDP per capita is $1,000. So significantly"},"679":{"dur":4,"text":"lower. You've seen health spending in low\nand middle-income countries triple over the"},"684":{"dur":5,"text":"last twenty years, but it is really low in\ncomparison to high-income settings."},"689":{"dur":6,"text":"All the governments of Sub-Saharan Africa\nspend as much as Poland on health care. If"},"695":{"dur":6,"text":"you combined all governments of all low and\nmiddle-income countries, representing 5.7"},"702":{"dur":5,"text":"billion people, their governments spend less\non health care than the United Kingdom, France,"},"708":{"dur":5,"text":"Germany and Canada combined, representing\nabout 260 million people."},"714":{"dur":4,"text":"At the same time, you've seen unprecedented\nrates of urbanization and a global integration"},"718":{"dur":5,"text":"of consumer markets driving an increase of\nrisk. So with people living longer but without"},"724":{"dur":6,"text":"access to preventative care, you are more\nlikely to get an NCD."},"730":{"dur":4,"text":"Without access to chronic care and without\nthe wealth to pay out of pocket, you're more"},"735":{"dur":5,"text":"likely to die and become disabled as a result.\nAs Tom mentioned before, these are having"},"740":{"dur":5,"text":"huge economic effects in these countries.\nIn some cases some destabilizing effects as"},"746":{"dur":3,"text":"well, and this is the reason why it's in the\nU.S.'s interests."},"749":{"dur":4,"text":"In terms of just briefly -- and I want to\nmake sure we leave time for Barbara because"},"754":{"dur":4,"text":"she has a lot of interesting things to say\non this topic. But in terms of why we think"},"759":{"dur":4,"text":"we can make progress on this, most people\ndon't realize how much progress we have made"},"763":{"dur":5,"text":"in high-income countries like the U.S., despite\nmuch higher rates of obesity, much higher"},"769":{"dur":6,"text":"rates of unhealthy habits, how we've dramatically\ncut mortality in under-sixty populations."},"776":{"dur":7,"text":"A lot of the interventions around that? Really\ncheap drugs for hypertension, tobacco control,"},"783":{"dur":10,"text":"vaccinations around hepatitis B and C, and\nfor HPV, for cervical cancer, things that"},"793":{"dur":4,"text":"can be done relatively cheaply but are not\nbroadly available in low and middle-income"},"798":{"dur":3,"text":"countries. And that's really where we focused.\nCHANG: Well Barbara, we want to bring you"},"801":{"dur":5,"text":"in at this point because not only is the private\nsector involved as large-scale employers,"},"806":{"dur":6,"text":"but also, you know, as actors and partners\nin the fight against noncommunicable diseases."},"812":{"dur":2,"text":"What impact might this have on businesses\nand what is possible?"},"815":{"dur":4,"text":"BYRNE: Well I'm sure you're wondering what\nis an investment banker doing focused on this"},"820":{"dur":6,"text":"issue. First, I'm sitting here in Mitch's\nseat. So -- but I tell you that it is critically"},"826":{"dur":8,"text":"important to -- I -- I deal with very large\nmultinational corporations who are incredibly"},"835":{"dur":5,"text":"focused. Right now, most of these guys get\n60 percent of their business from outside"},"840":{"dur":4,"text":"the United States. They're U.S. companies,\nbut they're very focused on developing countries,"},"845":{"dur":3,"text":"and they're actually very focused.\nThere's an alignment between what we're talking"},"849":{"dur":5,"text":"about here on the health issues and what the\nIBMs and the GEs, and I can go through a large"},"854":{"dur":3,"text":"range of companies that are focused -- focused\non -- in developing."},"858":{"dur":5,"text":"In particular, if I focus on the Sub-Saharan\nwhere we -- and I am familiar with Sub-Saharan"},"863":{"dur":4,"text":"because we're one of the largest banks, Barclays,\nin Africa. Sort of where -- you know, think"},"868":{"dur":4,"text":"about where the sun shined on the British\nEmpire. That's where we are."},"872":{"dur":6,"text":"And -- but in any event, this issue is critical\nfor that particular population. And when Tom"},"879":{"dur":6,"text":"talks about the lack of funding that is available\nin these countries, the opportunity that I"},"885":{"dur":6,"text":"think we have as a nation that -- that the\nU.S. has, is to be a convener on this topic."},"892":{"dur":4,"text":"And everybody thinks about, well where's the\nfunding going to come from, but major corporations"},"896":{"dur":6,"text":"will work with you on this to actually create\nwhat I would call the new type of NGO\/government\/corporate"},"902":{"dur":6,"text":"experience, the shared value type of initiative.\nAnd the data in this report -- and there was"},"909":{"dur":4,"text":"a lot of discussion. That was one of the more\ninteresting -- nobody -- this was not a group"},"914":{"dur":6,"text":"that agreed on everything, but there was -- which\nmade it fun. And -- but the data's fabulous,"},"920":{"dur":2,"text":"and the ability to be able to look at what\nis actually occurring."},"923":{"dur":5,"text":"Especially for me looking at the Sub-Sahara\nand where could you, especially with technology"},"928":{"dur":6,"text":"-- for example, HP is very active right now\nin Africa, very focused on what they can do"},"934":{"dur":6,"text":"on health care side. So there's a tremendous\nopportunity to act, and the world needs this"},"941":{"dur":5,"text":"type of leadership now because we're economically,\nas we all know, extremely fragile."},"946":{"dur":6,"text":"And with the kind of number we have at a $21.3\ntrillion -- OK, maybe it's off by 10 percent."},"952":{"dur":5,"text":"Who cares? It's -- whatever that number is,\nit's huge. And it's lost opportunity, and"},"958":{"dur":7,"text":"it's lost human capital, and that human capital\nfor what is a very minor cost can be added"},"965":{"dur":4,"text":"in. And quite frankly I think it's critical.\nCHANG: You've heard all three task members"},"969":{"dur":4,"text":"talk about the data. And Chris wanted to nudge\nme and tell everyone that not only are we"},"974":{"dur":6,"text":"livestreaming today on CFR.org, but we're\nalso providing a tremendous amount of interactive"},"981":{"dur":6,"text":"data on this task force result. So you know,\nI would encourage you all to look."},"987":{"dur":3,"text":"One of the things that struck me that you\nsaid earlier, Tom, was that, you know, the"},"990":{"dur":4,"text":"U.S. really doesn't have a strategy. There\nis no plan, and yet the task force really"},"995":{"dur":3,"text":"found that there are effective low-cost measures\nthat can go into effect."},"998":{"dur":3,"text":"DONILON: Yeah. That's I think exactly right.\nYou know, the -- the United States as we sit"},"1002":{"dur":5,"text":"here today does not have in its assistance\nprogram or in its global health program a"},"1008":{"dur":4,"text":"specific effort aimed at addressing the NCD\nproblem."},"1012":{"dur":4,"text":"And that's a principal recommendation of the\ngroup, obviously, is that the United States"},"1016":{"dur":7,"text":"should put in place a determined and specific\neffort and program with respect to NCDs. And"},"1024":{"dur":3,"text":"it can be done across a range of -- a range\nof -- range of ways."},"1027":{"dur":4,"text":"So one, an overall program. Two, that would\ninform our interaction with international"},"1031":{"dur":4,"text":"institutions and organizations in terms of\nmaking it a priority, as Barbara says, putting"},"1035":{"dur":4,"text":"the United States in a leadership role.\nThird, we'd recommend that it become also"},"1040":{"dur":4,"text":"a priority in our bilateral -- our bilateral\nrelationships with countries around the world,"},"1045":{"dur":4,"text":"especially these major countries like the\nBrazil and India and Chinas of the world."},"1050":{"dur":6,"text":"So yes, there is not a focused strategy. There\nshould be a focused strategy. And that conclusion"},"1056":{"dur":4,"text":"is driven not just by the general observation\nwe made about interest but about, as you said,"},"1060":{"dur":4,"text":"the fact that it's a -- it's a big problem\nand we can have fairly significant impact"},"1065":{"dur":3,"text":"for not that much money I think.\nCHANG: Tom, do you want to delve into some"},"1068":{"dur":5,"text":"of the policy aspects of the solutions?\nBOLLYKY: Sure. No, I'm happy to. First, I"},"1074":{"dur":5,"text":"should say on the data side, I want to make\nsure that I note the contributions of Chris"},"1079":{"dur":4,"text":"Murray and his team at the Institute of Health\nMetrics and Evaluation."},"1083":{"dur":5,"text":"It's really their Global Burden of Disease\nproject that provided some of the data for"},"1089":{"dur":4,"text":"this report and was very generous of them\nto share it. They shared it pre-publication."},"1094":{"dur":4,"text":"It will be coming out in out The Lancet later\nthis year. It's a type of collaboration you"},"1098":{"dur":5,"text":"don't often see in global health and is worth\nacknowledging."},"1103":{"dur":6,"text":"In terms of the recommendations, what we looked\nat is we looked at where are we making progress,"},"1110":{"dur":5,"text":"but you haven't seen that type of progress\nhappening in low and middle-income countries."},"1115":{"dur":6,"text":"And we put them in three categories.\nThere are the shovel-ready projects. Very"},"1121":{"dur":6,"text":"similar to our interventions around HIV, the\ntypes of things that can be -- aren't accessible"},"1128":{"dur":3,"text":"now in low and middle-income countries but\ncould be for cheap."},"1131":{"dur":8,"text":"In many ways, particularly in the current\nenvironment of budgetary and fiscal austerity,"},"1140":{"dur":7,"text":"NCDs are -- are the perfect agenda for austere\ntimes, and that many of the interventions"},"1147":{"dur":6,"text":"exist and could -- could be introduced.\nTo give you those on the shovel-ready projects,"},"1154":{"dur":5,"text":"we're talking again about cardiovascular disease,\nwhich causes one-fourth of all deaths in low"},"1160":{"dur":4,"text":"and middle-income countries but we've cut\ndramatically in the U.S. and other -- and"},"1164":{"dur":6,"text":"in other high-income countries despite much\nhigher rates, four times the rates of obesity"},"1170":{"dur":5,"text":"that exist in these countries.\nTobacco control. Again, working with interested"},"1175":{"dur":9,"text":"countries on having -- having strong tobacco\ncontrols in place. And given a task force"},"1184":{"dur":7,"text":"that was both bipartisan and had trade officials,\ndevelopment officials, private sector representation,"},"1191":{"dur":5,"text":"we have very strong recommendations on tobacco\ncontrol and they're worth noting."},"1197":{"dur":5,"text":"We also look at vaccinations around liver\ncancer, preventing liver cancer and cervical"},"1203":{"dur":4,"text":"cancer. That's the first category. Then we\nlooked at the range of activities where we've"},"1207":{"dur":4,"text":"actually made a lot of progress in high-income\ncountries, but you need more investment to"},"1212":{"dur":8,"text":"adapt those solutions for low-resource environments.\nAnd that's many of the cancers. We've seen"},"1220":{"dur":6,"text":"a lot of progress in cutting premature mortality\nrates from breast cancer, from leukemia, from"},"1227":{"dur":7,"text":"stomach cancer, areas like that. But most\nof the -- many of the diagnostic tools involved"},"1234":{"dur":6,"text":"in treatment aren't necessarily currently\nadaptable to low resource settings. And that"},"1240":{"dur":3,"text":"was really the second category.\nWe also look at diabetes, which the treatment"},"1244":{"dur":5,"text":"is actually quite cheap but is -- we need\nto see more progress on the prevention side."},"1250":{"dur":3,"text":"And that's true here and that's true in low\nand middle-income countries as well."},"1254":{"dur":7,"text":"The last category are -- we should acknowledge\nthere's a lot we don't know in -- around how"},"1261":{"dur":8,"text":"to prevent noncommunicable diseases. This\nis particularly true on nutrition, salt reduction,"},"1269":{"dur":4,"text":"a lot of the behavioral changes that you need\nto see."},"1273":{"dur":4,"text":"We don't have an answer to that. Nobody has\nan answer really to childhood obesity yet."},"1278":{"dur":4,"text":"The rates are much lower in these countries,\nbut they are becoming a problem everywhere."},"1282":{"dur":5,"text":"And these areas provide an opportunity for\ncollaboration with developing countries who"},"1288":{"dur":5,"text":"are having some success, particularly about\n-- around lower-cost models of chronic care,"},"1294":{"dur":3,"text":"and also the private sector.\nAnd I want to acknowledge Barbara's input"},"1297":{"dur":5,"text":"in this sector. It's really working with her\nthat we had a lot of good material come out"},"1303":{"dur":3,"text":"in this task force report about what would\nbe the role of the private sector."},"1306":{"dur":4,"text":"CHANG: Barbara, I'm curious if you look at\nit more through the lens of a workforce issue"},"1311":{"dur":7,"text":"or is it a, you know, economic impact on trading\npartners issue, or -- or is it both?"},"1319":{"dur":4,"text":"BYRNE: It's actually building -- building\nfrom the bottom of the economic pyramid. So"},"1323":{"dur":5,"text":"yes, that includes workforce, but any time\nyou have illness, even in a family where there"},"1329":{"dur":4,"text":"is workforce, it's a dramatic economic impact.\nSo -- you know, I can give you an example"},"1334":{"dur":5,"text":"of Zambia where -- which is a project I know\nfairly well. So one of the things that appeals"},"1339":{"dur":6,"text":"to me about this study and the thought of\nthe U.S. being a leader is having the convener."},"1346":{"dur":5,"text":"We're working in Zambia to help provide access\nthrough a particular project. We're working"},"1351":{"dur":6,"text":"with GSK. We're working with NGOs on the ground,\net cetera. And we -- do we have a legitimate"},"1358":{"dur":4,"text":"-- we being Barclays -- do we have a legitimate\nbusiness interest? Yes, but what would that"},"1362":{"dur":2,"text":"be?\nWell, ultimately if you are alive, you could"},"1364":{"dur":5,"text":"potentially be a customer of ours, right?\nSo there's a view -- when you -- it goes that"},"1370":{"dur":4,"text":"basic. And when you look at the world from\n-- and I'm trained as an economist in economics"},"1374":{"dur":4,"text":"-- you must have this part of the world contributing\nand healthy."},"1379":{"dur":4,"text":"And the cost, the intervention cost, what\nwe're doing in Zambia, is quite simple. We're"},"1383":{"dur":4,"text":"actually funding nurse practitioners as an\nalternative way of providing very basic health"},"1388":{"dur":5,"text":"care out in the bush. We're doing that together\nwith GSK. I'm sure their motivation is ultimately"},"1393":{"dur":6,"text":"they can sell pharmaceuticals there, but right\nnow there's just a government -- a government."},"1399":{"dur":4,"text":"So it's creating an alternative track.\nThey -- there are a lot of these what I would"},"1403":{"dur":6,"text":"call sub-scale projects occurring all around\nthe world with people with all -- who need"},"1410":{"dur":5,"text":"to have the government impact and need to\nbe able to focus on how to scale and how to"},"1416":{"dur":6,"text":"deal with those particular issues.\nThis -- and they are mostly NCD type issues."},"1422":{"dur":6,"text":"We're not talking about the, you know, communicable\ndiseases. Those are clearly a major issue,"},"1428":{"dur":7,"text":"but setting aside, these are lifestyle issues.\nSo we view it as economic bottom of the pyramid"},"1436":{"dur":3,"text":"growth and growing from our perspective in\nbusiness."},"1439":{"dur":5,"text":"I know major international corporations view\nthese markets -- developing markets as where"},"1445":{"dur":3,"text":"global growth will come from over the next\ntwenty years."},"1448":{"dur":5,"text":"CHANG: Tom, you talked a lot about the bilateral\nconsiderations and -- and working with other"},"1453":{"dur":3,"text":"governments. That's part of the task force\nrecommendation, and building those partnerships."},"1456":{"dur":4,"text":"You spent a lot of time meeting with heads\nof governments of the countries that I mentioned"},"1460":{"dur":3,"text":"in your profile.\nHow much of an appetite do you think there"},"1464":{"dur":4,"text":"will be among other nations to help support\nand build a coalition to help?"},"1468":{"dur":4,"text":"DONILON: I think -- I think -- you know, we\nhope that the task force report and the data"},"1473":{"dur":5,"text":"and the conclusions we reach will be an impetus\ntowards raising interest in -- in this issue,"},"1478":{"dur":2,"text":"number one.\nNumber two, in these -- in these strategic"},"1481":{"dur":5,"text":"dialogues we have with major partners around\nthe world, you know, I always find myself"},"1486":{"dur":6,"text":"looking for really high-impact win\/win projects,\nyou know? You know, I -- so I have had as"},"1493":{"dur":3,"text":"much interaction probably with the Chinese\nleadership as anybody in the last five or"},"1497":{"dur":3,"text":"six years.\nAnd you find on the natural that a lot of"},"1501":{"dur":4,"text":"those interactions are about problems. You\nknow, we have this problem with you. You have"},"1505":{"dur":6,"text":"this problem with us. And it's really important\nto have robust and effective win\/win kind"},"1512":{"dur":6,"text":"of positive agenda projects.\nAnd this seems to me to be a perfect -- a"},"1518":{"dur":7,"text":"perfect example of that, where they have issues\nin their own populations and issues in populations"},"1525":{"dur":3,"text":"in countries that they care about around the\nworld. So I do think it's a real opportunity"},"1529":{"dur":4,"text":"for increased bilateral -- increased bilateral\ncooperation."},"1533":{"dur":3,"text":"These are also very important countries in\n-- in international organizations that deal"},"1536":{"dur":3,"text":"with these -- that deal with these issues.\nCHANG: Tom, can you pick up on the NGOs, the"},"1540":{"dur":3,"text":"nongovernmental organizations that might have\nan impact?"},"1543":{"dur":6,"text":"BOLLYKY: Absolutely. So this is a underfunded\narea. To give you a sense of how underfunded"},"1550":{"dur":5,"text":"it is, if you look at the U.S. government,\nTom mentioned before there is no established"},"1556":{"dur":5,"text":"program. And you look at health spending by\nyear of disability loss."},"1561":{"dur":10,"text":"For HIV, that is about $44 per disability-adjusted\nlife year. For malaria, that's around $5."},"1571":{"dur":7,"text":"Tuberculosis, it's $1.80. And for NCDs it's\ntwo cents. Very low. If you -- most of the"},"1579":{"dur":4,"text":"funding that has come in this area is really\nfrom two sources."},"1584":{"dur":5,"text":"The first is the World Health Organization,\nwhich has been trying to generate interest"},"1589":{"dur":8,"text":"in this area for some time. And the second\nis the Bloomberg Foundation, which has contributed"},"1597":{"dur":5,"text":"significantly to this area. It is also a funder\nof this task force."},"1603":{"dur":4,"text":"You've seen increased interest in some areas.\nThe Bill and Melinda Gates Foundation has"},"1608":{"dur":8,"text":"recently announced more money to do tobacco\ncontrol in Africa. And there are some interests"},"1616":{"dur":3,"text":"from the other public\/private partnerships\nthat have been working on global health for"},"1620":{"dur":5,"text":"some time. Steve Davis was another task force\nmember and runs PATH, which is the largest"},"1625":{"dur":4,"text":"PDP in this area.\nSo I think there is some real space, particularly"},"1630":{"dur":4,"text":"around the adaptation of technologies that\ncould be used in these environments. That"},"1635":{"dur":6,"text":"would be a big help. In terms of the -- the\nbehavior change or social issues that will"},"1641":{"dur":3,"text":"happen for a long time, this is an area in\nwhich a lot of the global health NGOs have"},"1644":{"dur":4,"text":"really excelled for some time.\nMost people don't realize that the vast majority"},"1649":{"dur":4,"text":"of what we do in global health is already\naround behavioral change. Our biggest source"},"1653":{"dur":5,"text":"of funding -- biggest target of funding is\nHIV. The dominant modes of transmission around"},"1659":{"dur":5,"text":"HIV are behavioral. They're sex and IV drug\nuse."},"1664":{"dur":6,"text":"We've been at the behavior change game for\na long time, but we haven't necessarily addressed"},"1671":{"dur":3,"text":"some of these areas. And I think the NGOs\ncan really help."},"1674":{"dur":4,"text":"CHANG: With that, about half of the discussion\nis over and I wanted to open it up to the"},"1678":{"dur":5,"text":"audience so you can get your thoughts and\nyour questions. I would encourage you to raise"},"1684":{"dur":4,"text":"your hand. Yes? We'll get a microphone to\nyou."},"1688":{"dur":5,"text":"QUESTION: Hi. Jeff Laurenti. On page thirty-seven\nof the report, and Barbara's already alluded"},"1694":{"dur":6,"text":"to it, the report makes the case that the\nU.S. has its own economic interests in trying"},"1700":{"dur":5,"text":"to deal with this problem. One could argue,\nhowever, that there are within that larger"},"1706":{"dur":7,"text":"private sector interest specific private sector\ninterests that in fact may be partially or"},"1714":{"dur":5,"text":"substantially contributing.\nOne thinks first of tobacco. The Reagan administration"},"1719":{"dur":5,"text":"made breaking open markets for tobacco exports\none of its top trade priorities despite predictions"},"1724":{"dur":4,"text":"that within thirty years you would have lung\ncancer and heart disease pandemics, which"},"1729":{"dur":4,"text":"have happened just as had been predicted.\nYou have the food processing industry, which"},"1734":{"dur":4,"text":"has been subject to criticism at home to some\ndegree. And here it's the Europeans as much"},"1738":{"dur":7,"text":"as us, whether -- they have their equivalent\nto Coca-Cola and KFC. And arguably pharma,"},"1745":{"dur":6,"text":"the pharmaceuticals companies, all of which\nhave used international trade law and investment"},"1751":{"dur":5,"text":"law as a battering ram for being able to diffuse\ntheir products in poorer countries."},"1757":{"dur":9,"text":"To what extent do you all see that piece of\nthe wealthier world's very narrow, specific"},"1766":{"dur":7,"text":"industries selling goods with good advertising\nbudgets as part of the problem? To what extent"},"1774":{"dur":5,"text":"do you think the World Health Organization\nshould be given the authority to override"},"1780":{"dur":4,"text":"general trade liberalization provisions in\nexisting law?"},"1784":{"dur":6,"text":"Because page fifty-four refers to Obama's\npushing some exemption in the Trans-Pacific"},"1790":{"dur":3,"text":"Partnership, but it's WTO and TRIPS that are\nthe big guarantors."},"1794":{"dur":6,"text":"BYRNE: You know, it's interesting. Jeff -- I\nknow Jeff. The -- the problem on tobacco is"},"1801":{"dur":5,"text":"that tobacco in most of these countries is\nactually owned by their own government. These"},"1806":{"dur":6,"text":"are not the BATs or the -- the Philip Morrises,\net cetera. They're actually owned."},"1813":{"dur":4,"text":"You probably even saw yesterday in the New\nYork Times talking about the e-cigarettes"},"1817":{"dur":6,"text":"in China and the safety issues there. In particular,\nit's one of the largest single sources of"},"1823":{"dur":6,"text":"government funding in -- in China, is tobacco.\nThat's true actually in most parts of Africa"},"1830":{"dur":5,"text":"as well. It's true in India. It's true everywhere.\nAnd that actually -- you know, you don't want"},"1835":{"dur":4,"text":"to sit there and feel superior\ufffd-- but true\neverywhere as -- and countries have sold them"},"1839":{"dur":4,"text":"off.\nIt's -- within the realm of food, there is"},"1843":{"dur":6,"text":"not a huge amount in most of these countries\nof food going in. People are targeting, but"},"1850":{"dur":4,"text":"most of it -- maybe Coca-Cola, certainly the\ndistribution, but most of those guys have"},"1854":{"dur":3,"text":"been very good about sustainability and sourcing\nlocally."},"1858":{"dur":5,"text":"So I think it's important to remember that\nof course people do want to sell their products."},"1864":{"dur":4,"text":"But most of the products that you're talking\nabout are actually being controlled by self-same"},"1868":{"dur":7,"text":"governments, and that raises issues of its\nown in terms of how you can actually make"},"1875":{"dur":6,"text":"progress on them when it is indeed a source\nof funding for those -- for those governments."},"1881":{"dur":5,"text":"CHANG: Is there a hypocrisy sort of question\nwhen, you know, we're unleashing weapons of"},"1887":{"dur":8,"text":"mass obesity? Just made that up. Either Tom?\nBOLLYKY: So I'll just take the trade question"},"1896":{"dur":7,"text":"on because it's the one I know best. In terms\nof the task force report, we have a fairly"},"1903":{"dur":4,"text":"strong recommendation on tobacco and trade,\nand it was unanimous."},"1908":{"dur":5,"text":"This was remarkable in that there were three\nformer trade officials in these task force."},"1913":{"dur":7,"text":"It was bipartisan, and it makes a recommendation\nthat the announcement that the administration"},"1921":{"dur":7,"text":"has currently made that they are looking for\na potential exception in our trade negotiations"},"1928":{"dur":6,"text":"on tobacco should be -- should encompass the\nmeasures provided under U.S. law and provided"},"1935":{"dur":7,"text":"under international law, specifically the\nFramework Convention on Tobacco Control."},"1943":{"dur":5,"text":"Nice strong recommendation. We do not make\nas strong -- we don't make any recommendation"},"1948":{"dur":9,"text":"on food or beverages in this area. I think\nthere are good legal and policy reasons why."},"1957":{"dur":4,"text":"Tobacco is unusual in that it has an international\ntreaty. It's one of the most widely subscribed"},"1962":{"dur":3,"text":"treaties in the world.\nCompelling states that have signed on to this"},"1966":{"dur":5,"text":"treaty to take on these activities. President\nClinton issued a executive order compelling"},"1972":{"dur":5,"text":"U.S. agencies to take a certain approach on\ntobacco and not to promote tobacco."},"1978":{"dur":6,"text":"Tobacco is the only consumer product that\nwhen used as directed, kills you. It is not"},"1984":{"dur":6,"text":"-- it's different from food. It's different\nfrom the pharmaceuticals issues. And both"},"1990":{"dur":4,"text":"from a policy perspective and from a legal\nperspective, I think there are very strong"},"1994":{"dur":3,"text":"grounds for treating it differently under\na trade agreement."},"1998":{"dur":7,"text":"On the pharmaceutical side, the one thing\nI would mention in this area, one of the great"},"2006":{"dur":4,"text":"potential advantages for intervention around\nNCDs is a lot of these treatments already"},"2010":{"dur":8,"text":"exist for addressing noncommunicable disease,\nparticularly cardiovascular diseases."},"2019":{"dur":6,"text":"Treatments for diabetes have existed since\nthe 1920s. These are not -- it's by and large,"},"2026":{"dur":5,"text":"at a population level, these aren't issues\nof patents. These are -- the vast majority"},"2031":{"dur":5,"text":"of what needs to be distributed and adapted\nin these countries is off-patent."},"2037":{"dur":4,"text":"There's a lot of progress that can be made\nin this area. And particularly given limited"},"2041":{"dur":5,"text":"resources, we've talked about how -- another\nway of putting the resource disparities in"},"2046":{"dur":8,"text":"this area, of the U.S.'s $8 billion global\nhealth budget, we spend $10 million on noncommunicable"},"2054":{"dur":3,"text":"diseases.\nThe disparity is similar internationally."},"2057":{"dur":4,"text":"Given that kind of disparity, we should focus\non where we can make progress soonest."},"2061":{"dur":3,"text":"CHANG: Do you want to...\nDONILON: Just -- just for\ufffdthirty seconds."},"2065":{"dur":4,"text":"Jeff, the -- you know, we really -- we really\ndidn't try to -- where we focused on an issue,"},"2070":{"dur":2,"text":"we wanted to get to an issue where we could\ndo something about it."},"2072":{"dur":5,"text":"And with -- and with respect to -- and didn't\nengage every potential issue. With respect"},"2077":{"dur":7,"text":"to tobacco, there are tobacco control regimes\nwhich are proven and are effective and are"},"2085":{"dur":3,"text":"exportable and can make a big difference.\nAnd that was the conclusion of the task force"},"2088":{"dur":4,"text":"with respect to tobacco and endorsed, as you\npointed out, the president, Mike Froman's"},"2093":{"dur":4,"text":"exemption in the TTP negotiations.\nSo we didn't engage every potential element"},"2098":{"dur":6,"text":"here. We tried to focus in on those that were\nthe most important and where, most importantly,"},"2104":{"dur":5,"text":"we could make a difference. And tobacco, the\ntask force strongly believed, was one of those"},"2110":{"dur":4,"text":"areas.\nCHANG: I see a hand here."},"2115":{"dur":5,"text":"QUESTION: Elizabeth Cafferty, Women's Refugee\nCommission. Thank you very much for this report."},"2120":{"dur":4,"text":"I haven't read the whole thing, but one thing\nthat I didn't see in terms of how this could"},"2124":{"dur":5,"text":"be used as an advocacy tool really very immediately\nis the post-2015 sustainable development goal"},"2130":{"dur":3,"text":"process.\nAnd obviously the negotiations are beginning"},"2134":{"dur":5,"text":"in about a month's time and the indicators\ncould still be fleshed out, so it would be"},"2139":{"dur":5,"text":"interesting to hear your thoughts about that.\nI found it very sort of bilateral-focused"},"2144":{"dur":4,"text":"rather than sort of thinking about international,\nyou know, U.N. mechanisms, certainly being"},"2149":{"dur":2,"text":"here in New York.\nThe other thing which I would have hoped to"},"2151":{"dur":5,"text":"see more of is the data disaggregated by gender\nbecause I think that things would look really"},"2157":{"dur":4,"text":"different if we had that picture in front\nof us. And certainly gender norms -- there"},"2162":{"dur":3,"text":"are global gender norms which are shared,\nbut then again they're different by country"},"2166":{"dur":3,"text":"and region.\nAnd that's going to determine what we talk"},"2169":{"dur":5,"text":"about for prevention and response when we're\ndesigning interventions. And that is certainly"},"2174":{"dur":5,"text":"a place where both in the post-2015 but then\nagain bilaterally the U.S. could have -- I"},"2180":{"dur":4,"text":"mean, we don't have -- I agree we don't have\na sort of coherent global strategy."},"2185":{"dur":4,"text":"But certainly the CDC is doing really interesting\nthings on women's health and some reproductive"},"2189":{"dur":5,"text":"health. And State and AID are obviously involved\nas well. So perhaps you could speak to that"},"2194":{"dur":5,"text":"point as well. Thank you.\nBOLLYKY: I have good news for you. And when"},"2200":{"dur":6,"text":"you get to about two-thirds through the report,\nwe do talk about the SDGs, which is -- for"},"2206":{"dur":5,"text":"those of you who don't know, these are the\nsuccessor goals that will be put in place"},"2211":{"dur":3,"text":"after the Millennium Development Goals.\nThere are sadly going to be far too many of"},"2215":{"dur":9,"text":"them. I think by last count, something in\nthe area of 150 or 160. Yes. And one of them"},"2224":{"dur":7,"text":"will be on noncommunicable diseases. One of\nthem is expected to also be on tobacco control."},"2232":{"dur":6,"text":"We do talk about the opportunities that provides.\nWe also talk a bit but probably not enough"},"2238":{"dur":7,"text":"about the gender issues around noncommunicable\ndiseases. You do see a disproportionate impact,"},"2245":{"dur":5,"text":"particularly for certain noncommunicable diseases\non women and girls, and that's an issue that's"},"2251":{"dur":3,"text":"talked about in the report but probably could\nbe talked about more."},"2255":{"dur":6,"text":"DONILON: And a -- one of the specific recommendations\nis cervical cancer, where there's a -- obviously"},"2261":{"dur":5,"text":"a -- just a tremendous opportunity there for\n-- for a big impact."},"2267":{"dur":4,"text":"CHANG: Right, with the HPV vaccine, which\nis part of the recommendation. Yes?"},"2271":{"dur":9,"text":"QUESTION: I'm Charlie McCormick, president\nemeritus of Save the Children. The -- the"},"2280":{"dur":6,"text":"big numbers amongst the 8 million are in the\nPhilippines, Indonesia, China, India, et cetera."},"2287":{"dur":7,"text":"Middle level, middle-income countries. And\nnumber one, AID doesn't have a whole lot of"},"2294":{"dur":5,"text":"expertise in sort of policy change and social\nchange in these middle-income countries."},"2299":{"dur":7,"text":"They have very small missions in these particular\ncountries. So drilling down on your recommendations"},"2307":{"dur":7,"text":"on strategy, given this -- this context in\nwhich this problem is lodged, as it were,"},"2315":{"dur":5,"text":"what -- what additional modifications would\nyou have to recognize that these are countries"},"2320":{"dur":4,"text":"that have resources and capabilities and research\nand so on and so forth of their own? Thank"},"2325":{"dur":3,"text":"you.\nBOLLYKY: So just quickly, you'd be surprised."},"2328":{"dur":5,"text":"If -- we did\ufffdforty-nine country case studies\nof the burden of these diseases and we focused"},"2333":{"dur":5,"text":"on U.S. countries that received $5 million\nor more annually. We didn't want to do the"},"2338":{"dur":5,"text":"more -- the bigger population countries that\nreceived less. So for instance, China is not"},"2344":{"dur":6,"text":"in that grouping.\nAnd what we found is that in populations\ufffdfifty-nine"},"2351":{"dur":6,"text":"or younger, NCDs cost -- cause nearly 30 percent\nof the deaths in the countries that the U.S."},"2357":{"dur":5,"text":"currently targets with its global health programs,\nand more than a third of the disability in"},"2363":{"dur":3,"text":"the countries that we currently target in\nglobal health programs."},"2367":{"dur":4,"text":"For those of you who haven't seen the interactive\nonline, we have those country case studies"},"2371":{"dur":5,"text":"available. And you'll see low-income countries\nthat it causes more than 40 percent of the"},"2376":{"dur":4,"text":"deaths and disability.\nThese are the very same countries that we"},"2380":{"dur":5,"text":"currently invest in in global health. Another\nway of looking at this is non-communicable"},"2385":{"dur":6,"text":"diseases causes 3.5 times as much -- as many\npremature deaths in those\ufffdforty-nine countries"},"2392":{"dur":4,"text":"than HIV.\nIf you add HIV, malaria and TB combined, it"},"2396":{"dur":6,"text":"causes nearly two times more premature deaths\nthan those diseases. So these are countries"},"2403":{"dur":4,"text":"we've been invested in a long time, we have\nplatforms in. We just haven't been invested"},"2407":{"dur":4,"text":"in these issues.\nAnd we're seeing this epidemiological shift"},"2412":{"dur":4,"text":"in those countries, and the question is is\nhow are we going to respond that?"},"2416":{"dur":5,"text":"I mean ultimately -- I was at a global health\nconference, gosh, maybe a few months ago on"},"2422":{"dur":5,"text":"the best buys in global health. And there\nwas a U.S. agency representative there. I"},"2428":{"dur":5,"text":"won't say the person's name or the agency,\nbut somebody asked about, well what about"},"2433":{"dur":5,"text":"cardiovascular diseases is really cheap, or\nwhat about tobacco control? It's revenue generating"},"2438":{"dur":3,"text":"in most instances. Why aren't we focusing\non that?"},"2442":{"dur":5,"text":"And the agency representative said, well I'm\ninterested in the best buys for malaria and"},"2447":{"dur":5,"text":"HIV. And ultimately I think this becomes a\nquestion of why do we invest in global health?"},"2452":{"dur":6,"text":"And the justification in most of these issues\nare not -- these diseases aren't direct threats."},"2458":{"dur":4,"text":"People are not going to get malaria in the\nUnited States because people have malaria"},"2463":{"dur":5,"text":"in low-income countries. We invest in these\ndiseases because they affect poor people and"},"2468":{"dur":4,"text":"because we can do something about it, and\nit improves the welfare of those countries."},"2473":{"dur":4,"text":"That's true for noncommunicable diseases as\nwell. We just haven't responded to that. So"},"2477":{"dur":7,"text":"I -- I would just encourage people who haven't\nlooked at the -- the data. You might be surprised."},"2485":{"dur":6,"text":"CHANG: Yes?\nQUESTION: Thank you very much for bringing"},"2491":{"dur":5,"text":"this report to our attention. I'm Laurie Phipps\nfrom the U.S. Mission to the United Nations."},"2497":{"dur":8,"text":"And in 2011, the General Assembly held a high-level\nmeeting on the prevention and control of NCDs"},"2506":{"dur":5,"text":"and all the countries of the world at a high-level\nministerial level or above signed on to that."},"2511":{"dur":4,"text":"And a lot of what you've already discussed\nis included in the political declaration that"},"2516":{"dur":6,"text":"was adopted by the G.A. several years ago.\nThe U.S. approach to that document was to"},"2523":{"dur":5,"text":"try to keep the emphasis on prevention rather\nthan treatment, not because we don't want"},"2528":{"dur":5,"text":"to do treatment but because it's such an enormous\nand growing issue to try to treat all the"},"2534":{"dur":5,"text":"cardiovascular disease or diabetes in the\nworld, whereas if we can focus on prevention,"},"2540":{"dur":5,"text":"the burden will be less burdensome.\nAnd I'm wondering if you factored into your"},"2545":{"dur":7,"text":"study the -- the pronouncements of the General\nAssembly and the World Health Organization"},"2553":{"dur":5,"text":"on that and whether -- when you say that there's\nno U.S. policy, whether you're looking at"},"2559":{"dur":4,"text":"a more multisectoral approach and looking\nbeyond just the health sector and looking"},"2563":{"dur":6,"text":"into the sort of sectors that the first questioner\nmentioned with the -- the food industry and"},"2569":{"dur":6,"text":"the prevention that can come by better -- better\npolicies in that realm, and tobacco control,"},"2576":{"dur":6,"text":"which you've already talked about quite a\nbit, alcohol control and other efforts to"},"2583":{"dur":5,"text":"address the risk factors, as the U.N. calls\nthem. Thank you."},"2588":{"dur":7,"text":"BOLLYKY: So I would say on -- we do, and we\n-- all our shovel-ready interventions are"},"2596":{"dur":5,"text":"prevention. The cardiovascular disease, whether\nit's around hypertension or primary or secondary"},"2601":{"dur":6,"text":"prevention of cardiovascular disease prevention,\ntobacco control obviously is prevention, the"},"2608":{"dur":9,"text":"vaccinations and screening programs around\ncervical cancer and -- and hepatitis B are"},"2617":{"dur":3,"text":"all prevention.\nSo that -- you're completely right that this"},"2621":{"dur":6,"text":"needs to be a focus moving forward. There\nis no treatment solution to -- to noncommunicable"},"2627":{"dur":6,"text":"diseases. In terms of how it relates to the\nU.N. declaration, one of the things we tried"},"2634":{"dur":4,"text":"to do differently in this report than what\nwas done at the U.N., and I think it's -- was"},"2639":{"dur":7,"text":"an enormously useful exercise. It raised the\nprofile of these issues."},"2646":{"dur":5,"text":"And as I mentioned before, WHO has been really\ntrying to mobilize attention around noncommunicable"},"2651":{"dur":4,"text":"diseases since the late '80s, and they deserve\na lot of credit for that. One of the things"},"2656":{"dur":4,"text":"we wanted to do a bit different though in\nthis taskforce is we focused on low and middle-income"},"2660":{"dur":3,"text":"countries.\nAnd the reason why we did that is because"},"2664":{"dur":7,"text":"the drivers are different than high-income\ncountries. Again, to give you some evidence"},"2672":{"dur":5,"text":"of this, obesity rates in the United States\nare more than four times higher than they"},"2677":{"dur":4,"text":"are in low-income countries.\nThey're more than -- almost three times higher"},"2682":{"dur":5,"text":"than they are in lower middle-income countries.\nIf you had to focus somewhere in a low-income"},"2687":{"dur":5,"text":"country on noncommunicable diseases, focusing\non obesity probably shouldn't be your first"},"2692":{"dur":5,"text":"stop, given what the data is.\nThat doesn't mean it's not important. It just"},"2698":{"dur":3,"text":"-- again, the drivers are a little bit different.\nSo that's one of the things that we tried"},"2702":{"dur":5,"text":"to do to build on the great efforts that have\nhappened at the U.N. and other settings."},"2707":{"dur":6,"text":"In terms of the U.S. policy, it is true we're\ntalking about programs and budgets through"},"2713":{"dur":4,"text":"global health, but I'm not sure you see a\nlot in the development area either in this"},"2718":{"dur":6,"text":"space. There certainly is a fair amount happening\ndomestically looking at issues of tobacco"},"2724":{"dur":1,"text":"and nutrition."},"2725":{"dur":4,"text":"And part of what that does is provide an opportunity\nto expand that internationally, but so far"},"2730":{"dur":2,"text":"that hasn't -- hasn't happened yet. We're\nhoping to see more."},"2732":{"dur":3,"text":"DONILON: Yeah. I agree with that. You know,\nin terms of U.S. policy, so I was the national"},"2735":{"dur":6,"text":"security advisor in 2011, and we certainly\nhad to have a physician with respect to that"},"2742":{"dur":6,"text":"meeting, and did, but the United States doesn't\nhave this as a priority right now and it's"},"2749":{"dur":4,"text":"reflected in the budget.\nYou can't -- you cannot say that the United"},"2753":{"dur":6,"text":"States has as a high priority NCDs and have\nit be a $10 million project. That's just -- I"},"2759":{"dur":7,"text":"-- you know, I think back on the scale. You\nknow, we -- we -- we are trying to change"},"2767":{"dur":2,"text":"our focus in Afghanistan, move to a different\nphase on Afghanistan."},"2770":{"dur":5,"text":"You know, during 2011 for example, the year\nyou mentioned, we were spending $10 billion"},"2775":{"dur":8,"text":"a month in Afghanistan. So the scale here\nin terms of the real priority and potential"},"2783":{"dur":3,"text":"impact is really what we wanted to underscore\nhere."},"2787":{"dur":4,"text":"So in terms of -- yes, we'll have a physician\nat any given meeting, but we don't have a"},"2791":{"dur":4,"text":"real national -- we don't have a national\nstrategy, and it's not at the core of our"},"2795":{"dur":3,"text":"development and global health effort, I think\nis -- is the issue."},"2799":{"dur":5,"text":"And it's certainly not there in terms of resources.\nAnd that's -- those -- that's what we're trying"},"2804":{"dur":1,"text":"to underscore here in the..."},"2806":{"dur":1,"text":"CHANG: And what are you...\nDONILON: ... task force report. And it's not"},"2808":{"dur":4,"text":"-- for example, I don't know -- and I oversaw\nfor five years every one of these meetings."},"2812":{"dur":3,"text":"I don't know that we ever had an interagency\nmeeting on NCDs. And one of the -- and one"},"2816":{"dur":5,"text":"of the -- one of the things you hope to come\nforward from a report like this is to have"},"2822":{"dur":4,"text":"the government begin to look at it on an interagency\nbasis as a priority."},"2826":{"dur":6,"text":"CHANG: And were you to acquire resources for\nit, would it be you think best distributed"},"2832":{"dur":4,"text":"in the form of foreign aid or in -- what kind\nof leverage would you bring to that?"},"2837":{"dur":2,"text":"DONILON: Tom can give some details on this,\nbut the -- but there are a variety of ways"},"2839":{"dur":4,"text":"in which it can be -- which it can be done.\nBut the scale we're talking about here is"},"2844":{"dur":4,"text":"I think the figure we use -- Tom, remind me\n-- is $236 million is kind of a figure for"},"2848":{"dur":4,"text":"-- that was spent on tuberculosis last year.\nThat's kind of a figure we think would be"},"2852":{"dur":4,"text":"a figure here that could make progress across\nthe range of the recommendations that we've"},"2857":{"dur":3,"text":"put forward here.\nSo this is really not a lot -- this is -- this"},"2860":{"dur":5,"text":"is not -- this is not a lot of money. $236\nmillion would not really be a discussion point"},"2865":{"dur":3,"text":"in the defense budget.\nBOLLYKY: I mean, to give a sense, so that's"},"2869":{"dur":4,"text":"still\ufffdtwenty-three times more than what\nwe spend currently noncommunicable diseases"},"2874":{"dur":5,"text":"in the United States. So it is -- it's not\n-- it's not a lot, but it's significantly"},"2879":{"dur":5,"text":"more than we spend in that area.\nAnd we use the tuberculosis threshold to say,"},"2885":{"dur":6,"text":"here's a global health priority. It's not\nHIV, which takes up the bulk of the U.S. global"},"2891":{"dur":4,"text":"health budget, but it's something that we\ntake seriously. How much do we spend in that"},"2895":{"dur":2,"text":"area?\nAnd what the task force said is if we just"},"2898":{"dur":5,"text":"spent that much in this area, you could -- you\ncould start to really make some progress."},"2903":{"dur":4,"text":"It certainly isn't a number -- it's a number\nintended to indicate what the U.S. could do,"},"2908":{"dur":5,"text":"not what needs to be spent globally and primarily\nby the governments themselves to address their"},"2913":{"dur":4,"text":"noncommunicable disease problems. So I want\nto recognize that."},"2918":{"dur":4,"text":"And then we have -- we had that as a specific\nthreshold, but we also looked at the possibility"},"2923":{"dur":3,"text":"of working with partners. And maybe Barbara\nwants to say something on the private sector"},"2927":{"dur":3,"text":"end of what we recommend.\nBYRNE: I -- I -- the -- I -- I'll just go"},"2930":{"dur":7,"text":"back to, I've said it before, which is most\nmajor corporations actually are -- especially"},"2938":{"dur":6,"text":"in the last two to three years, are very focused\non wanting to work with NGOs specifically"},"2944":{"dur":6,"text":"on these types of issues in developing countries.\nAnd every -- and we're beginning to see elements"},"2950":{"dur":4,"text":"of that. I know we are. I know the major -- several\nof the major companies I've mentioned, but"},"2955":{"dur":7,"text":"more than that. And there is a lack of convening\non that topic. There -- there's a lot of good"},"2962":{"dur":7,"text":"intentions, and there is funding. Those organizations\nwill fund and will work."},"2969":{"dur":5,"text":"There's also, you know, many mistakes to be\nmade as you go in a learning process. But"},"2975":{"dur":6,"text":"I -- I -- I know that to be true. That's the\nentire shared value initiative and discussions"},"2981":{"dur":5,"text":"on that basis. And there's -- and I actually\nfor -- even just to set aside for my own firm,"},"2987":{"dur":3,"text":"chair something called the Social Innovation\nFacility, which is a facility that is set"},"2991":{"dur":4,"text":"side to specifically work on issues like that.\nSo -- and that -- multiply that by multiple"},"2996":{"dur":4,"text":"cooperations around the world. So there's\nfunding available outside of government. And"},"3000":{"dur":6,"text":"even more importantly, many of those organizations\nhave access into government for advocacy and"},"3006":{"dur":5,"text":"access into those markets in a way that can\nbe particularly helpful."},"3011":{"dur":8,"text":"CHANG: I saw your hand up over there.\nQUESTION: Thank you. I'm Jeff Sturchio with"},"3020":{"dur":4,"text":"Rabin Martin. I wanted to come back to the\nquestion that Laurie Phipps raised about the"},"3024":{"dur":6,"text":"2011 high-level meeting. And then particularly,\nMr. Donilon, on the point you made about how"},"3031":{"dur":5,"text":"it's clear just from the evidence, and this\nreport is full of terrific evidence, that"},"3037":{"dur":6,"text":"NCDs are not a U.S. priority.\nNow we've talked a lot about the policy recommendations"},"3044":{"dur":5,"text":"from the report. Those are all -- they all\nmake perfect sense to those of us who've been"},"3049":{"dur":5,"text":"involved in this for the last few years, but\nI want to come to another aspect of this and"},"3054":{"dur":5,"text":"ask you to just talk a bit if you would about\nthe political side of changing those priorities"},"3059":{"dur":5,"text":"and the allocation of resources.\nYou know, in 2011 the entire world agreed"},"3065":{"dur":5,"text":"at the U.N. that NCDs should be a priority,\nall countries would have NCD plans, there"},"3071":{"dur":4,"text":"would be an NCD global coordination mechanism,\nyou know, on and on and on. There were all"},"3075":{"dur":3,"text":"these commitments.\nWell it's now more than three years later."},"3079":{"dur":4,"text":"The global coordination mechanism, which was\nsupposed to help ensure that this work went"},"3084":{"dur":4,"text":"forward, is only now being organized. It has\nnot yet met. It's not actually doing anything"},"3088":{"dur":4,"text":"yet.\nAnd the political -- despite the political"},"3092":{"dur":6,"text":"declaration, that being followed with real\nresources that would change the situation"},"3099":{"dur":3,"text":"and make it possible to implement many of\nthe recommendations you've made, just hasn't"},"3102":{"dur":3,"text":"appeared.\nSo the question really is if we're going to"},"3105":{"dur":4,"text":"be serious about this and to find a way to\nput the -- the recommendations that you've"},"3110":{"dur":5,"text":"made into practice, what is the political\nroad map both in the U.S. Congress for instance"},"3115":{"dur":5,"text":"and also in the U.N. bodies, and more importantly\nin the national governments and the parliaments"},"3121":{"dur":4,"text":"that are going to have to really make in lower\nand middle-income countries the tough decisions"},"3125":{"dur":5,"text":"about where to allocate scarce resources?\nDONILON: Well again, I -- that's -- that's"},"3130":{"dur":4,"text":"one of the impacts you hope a report like\nthis has. And it's interesting. You know,"},"3135":{"dur":6,"text":"the -- the makeup of a task force I think\nis -- is -- is important here. You had, as"},"3142":{"dur":5,"text":"Tom said, you know, we had a number of trade\nofficials, and we came around a -- a unanimous"},"3147":{"dur":4,"text":"view with respect to tobacco control regime\nand trade issues."},"3152":{"dur":5,"text":"You had on this task force not just health\n-- health experts, but you had two former"},"3157":{"dur":4,"text":"national security advisors, myself and Sandy\nBerger, trying to look at the national security"},"3162":{"dur":3,"text":"side to this. You had people from the private\nsector and the financial sector."},"3165":{"dur":6,"text":"So the -- the goal here, having identified\nit as an important issue, having dug into"},"3172":{"dur":3,"text":"the research and the data and come to the\nconclusion that it is the most important health"},"3175":{"dur":3,"text":"issue facing low and moderate-income countries,\nthat it can have the kinds of effects that"},"3179":{"dur":6,"text":"we talked about, including undermining our\nreally successful contagious disease efforts."},"3186":{"dur":5,"text":"We would hope to raise this up in the -- in\nterms of the priorities of -- of the U.S."},"3191":{"dur":4,"text":"government. That's what these task forces\nare about, by the way. They're about U.S."},"3196":{"dur":4,"text":"policy. And that's -- that would be -- that\nwould be the goal here. And we'll -- and Tom"},"3200":{"dur":3,"text":"can talk about some of the interactions that\nwe'll -- that the task force and he will be"},"3204":{"dur":3,"text":"having with the government to brief on the\n-- to brief on the findings."},"3207":{"dur":6,"text":"BOLLYKY: Yeah, and we will be doing the range\nof White House executive branch briefings,"},"3213":{"dur":5,"text":"congressional briefings and foreign diplomatic\ncorps that we do really for all task force"},"3219":{"dur":3,"text":"reports.\nOne thing I want to say in this case, I think"},"3223":{"dur":4,"text":"the framing is important. And I think one\nof the challenges in 2011 is we looked at"},"3228":{"dur":6,"text":"this issue globally across all age ranges.\nThe solutions that came out of that, uniformly"},"3234":{"dur":7,"text":"you would hear about whole of societies approaches\nbeing necessary to make progress, a whole-of-governments"},"3241":{"dur":5,"text":"approaches being necessary to make progress\non these issues."},"3247":{"dur":5,"text":"I mean, at the WHO we're talking about twenty-five\n-- I get them confused. There are nine goals"},"3253":{"dur":5,"text":"and\ufffdtwenty-five indicators. This has been\npresented as a global problem across all age"},"3259":{"dur":7,"text":"ranges and something that we need to change\nagriculture, trade, cities, health systems"},"3267":{"dur":2,"text":"before you can make progress.\nAnd one of the things we've tried to do in"},"3269":{"dur":5,"text":"this report is actually this looks a lot like\na lot of global health issues. It's a problem"},"3274":{"dur":4,"text":"for the poor. It's a problem for the young\nworking-age populations, and it's a problem"},"3279":{"dur":3,"text":"in the same countries we've invested in in\nother areas."},"3282":{"dur":5,"text":"There are really specific, targeted things\nyou could do to help slow down the increase"},"3288":{"dur":6,"text":"of these diseases and help provide those governments\ntimes to tackle them themselves."},"3294":{"dur":5,"text":"And I think the framing of the -- the issue\nthe way we've done it with the data we've"},"3300":{"dur":3,"text":"done with it, we're hopeful -- in conjunction\nwith having wonderful people like Tom and"},"3303":{"dur":6,"text":"Barbara say this is important, we're hoping\nthat this looks different than what's been"},"3310":{"dur":3,"text":"done on NCDs before.\nCHANG: One of the many traditions of the Council"},"3313":{"dur":4,"text":"is to finish on time. So we are almost out\nof time, and I wanted to give you both an"},"3317":{"dur":6,"text":"opportunity to do a summation. And -- and\nthen we'll call it a day."},"3324":{"dur":6,"text":"BOLLYKY: All I would say in conclusion on\nthis is, again, this is not an issue that's"},"3330":{"dur":5,"text":"going away. It's a issue that will continue\nto increase. We're going to continue to work"},"3336":{"dur":5,"text":"on it. I want to thank Richard Haass, who\nhas had real interest in this personally,"},"3341":{"dur":4,"text":"and Chris Tuttle, who led the task force report\naround this, and the committee, for a great"},"3346":{"dur":3,"text":"effort.\nBYRNE: I just appreciate the opportunity to"},"3350":{"dur":6,"text":"have been part of it and to bring a voice\nto some of the major corporates who want to"},"3356":{"dur":4,"text":"be part of it as well and be on the team.\nDONILON: You know, I want to -- and let me"},"3360":{"dur":5,"text":"mention kind of the impact of these kinds\nof things. So there's many people here I know"},"3365":{"dur":4,"text":"-- when you're in the government, you know,\nthe coin of the realm and what you're really"},"3370":{"dur":5,"text":"sometimes desperate for is good intellectual\ncapital."},"3375":{"dur":3,"text":"You know, you have so many things you're dealing\nwith every day, right? You know, and you have"},"3379":{"dur":5,"text":"this huge inbox and it's easy to be in government\nand see the same people all the time who have"},"3385":{"dur":5,"text":"kind of come up with the same ideas.\nAnd -- and you get through your inbox and"},"3391":{"dur":3,"text":"you get through the problems on your -- on\nyour -- on your desk that say and you think"},"3394":{"dur":5,"text":"you've done a good job, but you haven't, because\nyou're just responding. And the impact of"},"3399":{"dur":5,"text":"things like CFR task forces and really powerful\nintellectual capital that's backed up with"},"3404":{"dur":3,"text":"data like this I think is significant.\nBecause again, you're just -- you're in the"},"3408":{"dur":5,"text":"-- you're just in the vortex constantly, and\nfresh intellectual capital coming into the"},"3414":{"dur":5,"text":"government, challenging ideas, reinforcing\nnew priorities, showing with specificity the"},"3419":{"dur":3,"text":"ways in which government can act I think is\na real -- hopefully is a real contribution,"},"3423":{"dur":3,"text":"I think can -- can change a number of -- it\ncertainly did in my time in government."},"3427":{"dur":5,"text":"Where you would have something that was -- that\nwas specific and compelling, implementable,"},"3433":{"dur":3,"text":"can have a real -- can have real impact.\nCHANG: That's where thought leadership is"},"3436":{"dur":3,"text":"invaluable. Thank you so much for contributing\nto the task force, Chris, everyone else here"},"3440":{"dur":2,"text":"who took part, and thanks for being with us\ntoday. Have a great day."},"3442":{"dur":0,"text":"END"}}